United States · Wires & real time · Business Wire

Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting

Published by Business Wire · United States 15 h ago

– SMPA to present first data from ongoing Phase 2 clinical trial of enzomenib in patients with relapsed or refractory acute leukemia, with KMT2A rearrangements, an aggressive…

Read the full article on Business Wire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)

Also worth reading

Associated Press (Business)

Bangladesh garment factories close as workers clash with police in pay protests

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires

Sumitomo Pharma America to Present New Clinical Data on Enzomenib and Nuvisertib at the 2026 American Society of Hematology Annual Meeting

Share

Also worth reading

Bangladesh garment factories close as workers clash with police in pay protests

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot